Identification of Potential Molecular Mechanisms and Candidate Drugs for Radiotherapy- and Chemotherapy-induced Mucositis

Overview

Journal Support Care Cancer

Specialties Critical Care
Oncology

Date 2023 Mar 20

PMID 36939936

Authors

Siyuan Hao

Yixin Jin

Yue Yu

Jiantao Wang

Jing Zou

Yan Wang

Affiliations

Soon will be listed here.

Abstract

Background: Radiotherapy-induced oral mucositis (RIOM) and chemotherapy-induced oral mucositis (CIOM) are common complications in cancer patients, leading to negative clinical manifestations, reduced quality of life, and unsatisfactory treatment outcomes.

Objective: The present study aimed to identify potential molecular mechanisms and candidate drugs by data mining.

Methods: We obtained a preliminary list of genes associated with RIOM and CIOM. In-depth information on these genes was explored by functional and enrichment analyses. Then, the drug-gene interaction database was used to determine the interaction of the final enriched gene list with known drugs and analyze the drug candidates.

Results And Conclusion: This study identified 21 hub genes that may play an important role in RIOM and CIOM, respectively. Through our data mining, bioinformatics survey, and candidate drug selection, TNF, IL-6, and TLR9 could play an important role in disease progression and treatment. In addition, eight candidate drugs (olokizumab, chloroquine, hydroxychloroquine, adalimumab, etanercept, golimumab, infliximab, and thalidomide) were selected by the drug-gene interaction literature search additionally, as candidates for treating RIOM and CIOM.

Citing Articles

Effects of Curcumin on Radiation/Chemotherapy-Induced Oral Mucositis: Combined Meta-Analysis, Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation.

Chen Z, Qin Y, Shi B, Gao B, Tao R, Yong X Curr Issues Mol Biol. 2024; 46(9):10545-10569.

PMID: 39329977 PMC: 11431004. DOI: 10.3390/cimb46090625.

Nuclear Receptors and Stress Response Pathways Associated with the Development of Oral Mucositis Induced by Antineoplastic Agents.

Kagaya M, Uesawa Y Pharmaceuticals (Basel). 2024; 17(8).

PMID: 39204191 PMC: 11358984. DOI: 10.3390/ph17081086.

Contributing Role of High Mobility Group Box 1 Signaling in Oral Cancer Development and Therapy.

Plemmenos G, Tzimogianni V, Fili C, Piperi C Life (Basel). 2023; 13(7).

PMID: 37511951 PMC: 10381251. DOI: 10.3390/life13071577.

References

Scully C, Epstein J, Sonis S . Oral mucositis: a challenging complication of radiotherapy, chemotherapy, and radiochemotherapy: part 1, pathogenesis and prophylaxis of mucositis. Head Neck. 2003; 25(12):1057-70. DOI: 10.1002/hed.10318. View

Sonis S . Pathobiology of oral mucositis: novel insights and opportunities. J Support Oncol. 2007; 5(9 Suppl 4):3-11. View

Sonis S . New thoughts on the initiation of mucositis. Oral Dis. 2010; 16(7):597-600. DOI: 10.1111/j.1601-0825.2010.01681.x. View

Logan R, Gibson R, Bowen J, Stringer A, Sonis S, Keefe D . Characterisation of mucosal changes in the alimentary tract following administration of irinotecan: implications for the pathobiology of mucositis. Cancer Chemother Pharmacol. 2007; 62(1):33-41. DOI: 10.1007/s00280-007-0570-0. View

Pulito C, Cristaudo A, La Porta C, Zapperi S, Blandino G, Morrone A . Oral mucositis: the hidden side of cancer therapy. J Exp Clin Cancer Res. 2020; 39(1):210. PMC: 7542970. DOI: 10.1186/s13046-020-01715-7. View

Al-Dasooqi N, Sonis S, Bowen J, Bateman E, Blijlevens N, Gibson R . Emerging evidence on the pathobiology of mucositis. Support Care Cancer. 2013; 21(7):2075-83. DOI: 10.1007/s00520-013-1810-y. View

McCullough R . US oncology-wide incidence, duration, costs and deaths from chemoradiation mucositis and antimucositis therapy benefits. Future Oncol. 2017; 13(30):2823-2852. DOI: 10.2217/fon-2017-0418. View

Gruber S, Bozsaky E, Roitinger E, Schwarz K, Schmidt M, Dorr W . Early inflammatory changes in radiation-induced oral mucositis : Effect of pentoxifylline in a mouse model. Strahlenther Onkol. 2017; 193(6):499-507. PMC: 5438416. DOI: 10.1007/s00066-017-1119-8. View

Villa A, Sonis S . An update on pharmacotherapies in active development for the management of cancer regimen-associated oral mucositis. Expert Opin Pharmacother. 2020; 21(5):541-548. DOI: 10.1080/14656566.2020.1718652. View

10.

Nicolatou-Galitis O, Sarri T, Bowen J, Palma M, Kouloulias V, Niscola P . Systematic review of anti-inflammatory agents for the management of oral mucositis in cancer patients. Support Care Cancer. 2013; 21(11):3179-89. DOI: 10.1007/s00520-013-1847-y. View

11.

Kirk J, Shah N, Noll B, Stevens C, Lawler M, Mougeot F . Text mining-based in silico drug discovery in oral mucositis caused by high-dose cancer therapy. Support Care Cancer. 2018; 26(8):2695-2705. DOI: 10.1007/s00520-018-4096-2. View

12.

Ashburn T, Thor K . Drug repositioning: identifying and developing new uses for existing drugs. Nat Rev Drug Discov. 2004; 3(8):673-83. DOI: 10.1038/nrd1468. View

13.

Pushpakom S, Iorio F, Eyers P, Jane Escott K, Hopper S, Wells A . Drug repurposing: progress, challenges and recommendations. Nat Rev Drug Discov. 2018; 18(1):41-58. DOI: 10.1038/nrd.2018.168. View

14.

Yu S, Tranchevent L, De Moor B, Moreau Y . Gene prioritization and clustering by multi-view text mining. BMC Bioinformatics. 2010; 11:28. PMC: 3098068. DOI: 10.1186/1471-2105-11-28. View

15.

Berg E . Systems biology in drug discovery and development. Drug Discov Today. 2013; 19(2):113-25. DOI: 10.1016/j.drudis.2013.10.003. View

16.

Kang P, Kalloniatis M, Doig G . Using Updated PubMed: New Features and Functions to Enhance Literature Searches. JAMA. 2021; 326(6):479-480. DOI: 10.1001/jama.2021.12021. View

17.

Rani J, Shah A, Ramachandran S . pubmed.mineR: an R package with text-mining algorithms to analyse PubMed abstracts. J Biosci. 2015; 40(4):671-82. DOI: 10.1007/s12038-015-9552-2. View

18.

Kanehisa M, Furumichi M, Tanabe M, Sato Y, Morishima K . KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 2016; 45(D1):D353-D361. PMC: 5210567. DOI: 10.1093/nar/gkw1092. View

19.

Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi A, Tanaseichuk O . Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019; 10(1):1523. PMC: 6447622. DOI: 10.1038/s41467-019-09234-6. View

20.

Chen X, Robinson D, Storey J . The functional false discovery rate with applications to genomics. Biostatistics. 2019; 22(1):68-81. PMC: 7846131. DOI: 10.1093/biostatistics/kxz010. View